|
2025 Journal Article Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1 UK lineageRichter, Johanna, Cork, Amanda J., Ong, Yvette, Keller, Nadia, Hayes, Andrew J., Schembri, Mark A., Jennison, Amy V., Davies, Mark R., Schroder, Kate, Walker, Mark J. and Brouwer, Stephan (2025). Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1 UK lineage. mBio, 16 (2) e0336624, e0336624. doi: 10.1128/mbio.03366-24 |
|
2024 Journal Article Efficacy of alum-adjuvanted peptide and carbohydrate conjugate vaccine candidates against Group A Streptococcus pharyngeal infection in a non-human primate modelRivera-Hernandez, Tania, Carnathan, Diane G., Richter, Johanna, Marchant, Patrick, Cork, Amanda J., Elangovan, Gayathiri, Henningham, Anna, Cole, Jason N., Choudhury, Biswa, Moyle, Peter M., Toth, Istvan, Batzloff, Michael R., Good, Michael F., Agarwal, Paresh, Kapoor, Neeraj, Nizet, Victor, Silvestri, Guido and Walker, Mark J. (2024). Efficacy of alum-adjuvanted peptide and carbohydrate conjugate vaccine candidates against Group A Streptococcus pharyngeal infection in a non-human primate model. Vaccines, 12 (4) 382, 1-10. doi: 10.3390/vaccines12040382 |
|
2020 Journal Article Vaccine-induced Th1-type response protects against invasive group A Streptococcus infection in the absence of opsonizing antibodiesRivera-Hernandez, Tania, Rhyme, Mira Syahira, Cork, Amanda J., Jones, Scott, Segui-Perez, Celia, Brunner, Livia, Richter, Johanna, Petrovsky, Nikolai, Lawrenz, Maria, Goldblatt, David, Collin, Nicolas and Walker, Mark J. (2020). Vaccine-induced Th1-type response protects against invasive group A Streptococcus infection in the absence of opsonizing antibodies. mBio, 11 (2) e00122-20. doi: 10.1128/mbio.00122-20 |
